Berlin category | 0 | 1 | 2 | 3 | P-value |
---|---|---|---|---|---|
N = 53 | N = 9 | N = 32 | N = 7 | ||
Age, years | 61 (30) | 71 (22) | 63 (24) | 69 (29) | 0.21 |
Sex, male | 39 (74) | 5 (56) | 20 (63) | 5 (71) | 0.60 |
SAPS II admission | 46 (20) | 59 (24) | 49 (16) | 44 (57) | 0.39 |
SOFA D0 | 7 (4) | 8 (5) | 9 (5) | 10 (5) | 0.06 |
ICU days until inclusion | 6 (12) | 7 (19) | 8 (12) | 9 (32) | 0.98 |
CVP D0, mmHg | 9 (5) | 5 (2) | 6 (6) | 7 (3) | 0.26 |
CVP D1, mmHg | 8 (5) | 6 (5) | 7 (4) | 6 (0) | 0.83 |
CVP D2, mmHg | 7 (4) | 9 (2) | 6 (4) | 5 (0) | 0.25 |
CVP D7, mmHg | 7 (4) | 9 (4) | 7 (5) | 9 (1) | 0.49 |
Vasopressor use D0-7 | 28 (53) | 6 (67) | 23 (72) | 5 (71) | 0.20 |
Renal replacement therapy D0-7 | 3 (6) | 1 (11) | 4 (13) | 0 | 0.57 |
Albumin 20% administration (100 mL) D0-7 | 3 (6) | 2 (22) | 8 (25) | 0 | 0.03 |
Corticosteroids use D -7-0 | 23 (43) | 5 (56) | 14 (44) | 3 (43) | 0.92 |
Corticosteroid use D 0-7 | 23 (43) | 7 (78) | 16 (50) | 4 (57) | 0.28 |
28-day mortality | 9 (17) | 4 (44) | 10 (31) | 3 (43) | 0.15 |
LIS category | LIS <1 | LIS 1.0-2.5 | LIS >2.5 | ||
N =14 | N = 69 | N =18 | P-value | ||
Age, years | 62 (28) | 63 (24) | 59 (28) | 0.92 | |
Sex, man | 10 (71) | 47 (68) | 12 (67) | 0.96 | |
SAPS II at admission | 49 (20) | 47 (20) | 45 (23) | 0.35 | |
SOFA D0 | 5 (2) | 8 (5) | 10 (3) | 0.004 | |
ICU days until inclusion | 6 (14) | 7 (9) | 6 (12) | 0.85 | |
CVP D0, mmHg | 8 (6) | 7 (5) | 8 (5) | 0.79 | |
CVP D1, mmHg | 7 (4) | 7 (6) | 7 (4) | 0.50 | |
CVP D2, mmHg | 3 (0) | 7 (3) | 7 (6) | 0.32 | |
CVP D7, mmHg | 6 (7) | 7 (5) | 8 (3) | 0.61 | |
Vasopressor use D0-7 | 5 (39) | 4 (63) | 14 (82) | 0.05 | |
Renal replacement therapy D0-7 | 0 | 7 (10) | 1 (6) | 0.40 | |
Albumin 20% administration (100 mL) D 0-7 | 0 | 12 (17) | 1 (6) | 0.12 | |
Corticosteroids use D -7-0 | 6 (43) | 31 (45) | 8 (44) | 0.99 | |
Corticosteroid use D 0-7 | 4 (29) | 35 (51) | 11 (61) | 0.18 | |
28-day mortality | 2 (14) | 18 (26) | 6 (33) | 0.47 |